June 12, 2018
Alvogen, Pfenex in a US marketed osteoporosis drug commercialization deal
Alvogen and Pfenex have signed a deal which grants Alvogen exclusive rights to commercialize Pfenex’s lead drug candidate, PF708, a…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Pfenex
December 19, 2017
Pfenex cashes $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals
Pfenex has announced the amendment of the 2016 agreement under which Pfenex granted Jazz Pharmaceuticals worldwide rights to develop and…
September 8, 2017
Pfenex CFO and CMO leave
USA-based clinical-stage biotechnology company Pfenex Inc. is saying goodbye to its Chief Financial Officer, Dr. Paul Wagner, who has been said on…